Sundia will hold a session conference with Oscotec Inc. Bridge Biotherapeutics, Inc. and U-Chem at BioKorea in the morning of April 18th, 2019. We invited Dr. Jung-Ho Kim ,(Executive Director, CTO)of Oscotec Inc. and Dr. Sang Uk Kang,( SVP, Head of R&D) of Bridge Biotherapeutics, Inc. to share their views about how CRO companies can help pharmaceutical companies to better and faster get approved on IND Filing. We welcome you to participate in and discuss with us.
Date: Wednesday，April 18th 9:00~12:00，2019
Partnering to success on IND filing
A Start up’s Approach from Discovery to Development
Drug Development Strategy in NRDO Biotech Company
Points ofConsideration to US FDA IND in CMC
Dr. Hui-Yi Shiao, Director, Regulatory Affair. Sundia MediTech Company, Ltd.
Also we will exhibit from Apr 17th to 19th. Our booth number is #K22.
Venue: COEX, Seoul,Korea
To make an appointment, please contact us via email email@example.com.
Find more information at http://www.biokorea.org/program/conference_02.asp